What phototherapy actually involves
Phototherapy is a treatment in which a clinician uses a measured dose of ultraviolet light to treat certain skin conditions. Narrowband ultraviolet B (NB-UVB) is one established form, used for some widespread inflammatory skin diseases, and psoralen plus ultraviolet A (PUVA) is another established approach in which a light-sensitising medicine is taken before UVA exposure. Both are medical treatments, not cosmetic light sessions, and both carry real risks that the prescribing dermatologist must weigh against the expected benefit.
The treatment is usually delivered in a dedicated unit with calibrated lamps or a cabin. A course involves repeated sessions, and the dose is adjusted according to how the skin responds. Because the response and the safe dose differ between people, the schedule is set by the treating team rather than by a general rule. Some patients are treated as outpatients who attend for each session; others may be admitted for part of a course if their condition or circumstances require it. Which model applies to you is a question for the hospital.
It helps to separate three things that patients often blur together: the diagnosis, the decision to use phototherapy, and the logistics of attending sessions. A dermatologist confirms the first, recommends or declines the second, and the hospital arranges the third. No coordinator can substitute for that clinical sequence.
The safety questions to settle before you travel
Phototherapy is generally well tolerated when supervised, but it is not risk-free. Short-term effects can include redness, dryness, itching and, in some people, a sunburn-like reaction if the dose is too high. Longer-term ultraviolet exposure is associated with premature skin ageing and an increased risk of skin cancer, which is why cumulative dose and the number of courses matter. PUVA adds the effects of the sensitising medicine, including nausea and the need for strict eye protection on treatment days. These are reasons for a proper dermatology assessment, not reasons to avoid asking about the treatment.
The key safety question is whether phototherapy is appropriate for your particular skin problem at all. Some conditions respond well; others do not, and some skin diseases can be worsened by ultraviolet light. Certain medicines and some medical conditions increase sensitivity to light or make ultraviolet treatment unsafe. Photosensitivity disorders, a history of skin cancer, and pregnancy each need specific discussion with the dermatologist. If you have any of these, say so at the first contact rather than after a plan is set.
You should also ask how your skin type and any recent sun exposure will be handled, because starting doses are individualised. If you have been using topical treatments, tanning beds or sunbeds, or have had recent ultraviolet exposure, the team needs to know. Do not stop or change prescribed medicines on your own before the assessment; raise the question with the dermatologist and your current prescriber.
Records that make a dermatology review possible
A useful review starts with the skin history, not with a request for a full archive. For an initial enquiry, a short summary is enough: what the skin problem is, how long it has been present, what has been tried, and what you want to know. Photographs taken in consistent, natural light can help the team understand the distribution and appearance of the rash or lesions, but they do not replace an in-person examination.
For the clinical assessment itself, the dermatologist will want the records that explain your diagnosis and treatment so far. These typically include clinic letters and dermatology notes, biopsy or pathology reports if a sample was taken, blood test results relevant to your condition, and a list of current medicines with doses, including creams, tablets and any light-sensitising drugs. If you have had phototherapy before, the previous doses, number of sessions and response are directly relevant, because cumulative ultraviolet exposure is part of the safety picture.
Ask the hospital what it needs in what format, and whether translated summaries are acceptable or whether original reports are preferred. Do not send passport numbers, payment details or a complete medical archive through an initial web form. Share clinical documents only through the channel the provider confirms. If some records are missing, say so; the team can tell you whether the assessment can proceed or what would make it more reliable.
How a course is planned and monitored in practice
Once phototherapy is recommended, the treating team sets a starting dose, a session schedule and a review point. Doses are adjusted according to the skin's response, so the plan is not fixed at the outset. The team will also explain how to protect unaffected skin, what to do if redness or blistering occurs, and when to contact the unit between sessions. Eye protection during PUVA treatment and, depending on the protocol, during NB-UVB is part of the instructions the unit gives.
Monitoring is not only about the skin. The dermatologist will review how the condition is responding, whether the treatment is still justified, and whether the cumulative dose is becoming a concern. Ask how response will be judged, what would prompt a change of plan, and what happens if the condition does not improve. These are clinical decisions, and the answers should come from the treating dermatologist rather than from a general article.
Practical questions matter too, because phototherapy requires repeated attendance. Ask how sessions are booked, whether the unit treats international patients, what language support is available, and how appointment changes are handled. Confirm the answers with the specific hospital rather than assuming a schedule. If your treatment plan involves other therapies, ask how phototherapy fits alongside them and who coordinates the overall plan.
Costs, coordination and what an estimate should cover
Phototherapy is charged by the treating hospital, and the amount depends on the assessment, the type of phototherapy, the number of sessions and any related tests or reviews. No single figure applies across hospitals or patients, and this guide does not quote one. Ask the hospital for a written estimate that states what is included, such as the dermatology consultation, the treatment sessions, any medicines used for PUVA, and follow-up review. Ask separately about anything the estimate does not cover.
Our role is non-clinical coordination: helping with enquiries, appointment registration, interpretation and practical arrangements, with agreed coordination fees separate from hospital charges. We do not decide whether phototherapy is suitable, set the dose, or guarantee hospital acceptance. A free initial case review checks the available information and the main question, identifies what is missing, and suggests a next step. A proxy consultation, where a doctor takes records to a hospital specialist while you remain at home, is optional and not a prerequisite for an appointment.
Before committing to travel, ask the hospital what would make the visit worthwhile and what could be handled remotely. Some preparation and records review may be possible before you arrive; the extent depends on the provider. Confirm the plan in writing rather than relying on a verbal outline.
A realistic next step
If you are considering phototherapy in China, start with a short summary of your skin condition, your current treatment and your main question. Ask the dermatology team three things: whether phototherapy is appropriate for your diagnosis, what records they need for a reliable assessment, and what their written plan and estimate include. Keep your current care in place until a treating clinician advises otherwise, and seek local urgent care for severe or rapidly worsening skin symptoms rather than delaying for travel.
An initial enquiry with ChinaSpecialistCare is free and does not commit you to a proxy consultation or any paid service. The hospital and its dermatologists decide suitability, the treatment plan and acceptance.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.
